SYRS insider trading

CIK 1556263

Syros Pharmaceuticals, Inc.: insider trade history from SEC Form 4 filings.

Form 4 trades
236
Last 90 days
0
Buys / sells
14% / 25%
Insiders
32

SYRS insider activity at a glance

FilingIQ tracks 236 insider transactions for SYRS in filings since Jul 6, 2016. The most recent transaction is dated Dec 2, 2024. They were reported by 32 insiders.

Across the full history, 32 open-market purchases and 58 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest SYRS Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to SYRS by Form 4 lines in the last 90 days, the number on each card.

Frequently asked

How many insider trades does FilingIQ track for SYRS?
FilingIQ tracks 236 Form 4 insider transactions for SYRS (Syros Pharmaceuticals, Inc.), covering filings from Jul 6, 2016 onwards. 0 of those are dated within the last 90 days.
Are SYRS insiders net buyers or net sellers?
Across the full Form 4 history for SYRS, 32 transactions (14%) were open-market purchases and 58 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SYRS insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every SYRS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.